Agentix Corp
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, … Read more
Agentix Corp (AGTX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.001x
Based on the latest financial reports, Agentix Corp (AGTX) has a cash flow conversion efficiency ratio of -0.001x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.00K) by net assets ($-3.42 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Agentix Corp - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Agentix Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Agentix Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Agentix Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gossan Resources Ltd
V:GSS
|
-0.341x |
|
Dalrada Financial Corp
PINK:DFCO
|
0.335x |
|
Panbela Therapeutics Inc
NASDAQ:PBLA
|
0.117x |
|
Instituto Rosenbusch S.A.
BA:ROSE
|
-0.133x |
|
Intra Energy Corporation
AU:IEC
|
0.000x |
|
WarpSpeed Taxi Inc
PINK:WRPT
|
0.050x |
|
Melar Acquisition Corp. I Warrant
NASDAQ:MACIW
|
N/A |
|
CURAA
NSE:CURAA
|
N/A |
Annual Cash Flow Conversion Efficiency for Agentix Corp (2013–2025)
The table below shows the annual cash flow conversion efficiency of Agentix Corp from 2013 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $-3.10 Million | $-125.08K | 0.040x | -6.58% |
| 2024-03-31 | $-2.56 Million | $-110.43K | 0.043x | +9.57% |
| 2023-03-31 | $-2.25 Million | $-88.54K | 0.039x | +102.09% |
| 2022-03-31 | $223.46K | $-420.98K | -1.884x | -113.66% |
| 2021-03-31 | $-125.78K | $110.91K | -0.882x | -278.79% |
| 2020-03-31 | $-125.78K | $-62.03K | 0.493x | -49.18% |
| 2019-03-31 | $-53.13K | $-51.56K | 0.970x | -17.35% |
| 2018-03-31 | $-65.08K | $-76.42K | 1.174x | +194.72% |
| 2017-03-31 | $10.14K | $-12.58K | -1.240x | +93.27% |
| 2016-03-31 | $10.15K | $-186.92K | -18.414x | -1039.39% |
| 2014-03-31 | $119.98K | $-193.90K | -1.616x | -182.82% |
| 2013-03-31 | $70.00K | $-40.00K | -0.571x | -- |